NEW YORK (GenomeWeb News) – Three research teams developing molecular breast cancer diagnostic technologies at US universities have been chosen as winners of a competition aimed at helping them develop business plans to commercialize their innovations.

At total of 10 teams were selected as winners of the Breast Cancer Startup Challenge, a competition funded and led by the Avon Foundation for Women and supported by the National Cancer Institute and the Center for Advancing Innovation, the Avon Foundation said yesterday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.